BIOBIJOU Income Statement

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Revenue	34,001	29,633	17,130
Revenue Growth (YoY)	-	72.99%	-
Cost of Revenue	16,149	14,815	8,871
Gross Profit	17,852	14,819	8,259
Selling, General & Admin	6,644	3,982	2,311
Research & Development	766.15	1,213	632.7
Other Operating Expenses	58.82	47.52	29.74
Operating Expenses	7,857	5,592	3,094
Operating Income	9,994	9,227	5,165
Interest Expense	-145.43	-444.24	-594.63
Interest & Investment Income	127.33	205.4	126.48
Currency Exchange Gain (Loss)	-503.26	765.23	400.31
Other Non Operating Income (Expenses)	10.31	-922.33	-949.25
EBT Excluding Unusual Items	9,483	8,831	4,148
Gain (Loss) on Sale of Investments	181.4	148.3	79.14
Gain (Loss) on Sale of Assets	-	-	0.65
Pretax Income	9,665	8,979	4,227
Income Tax Expense	1,850	1,791	917.41
Net Income	7,814	7,188	3,310
Net Income to Common	7,814	7,188	3,310
Net Income Growth	-	117.16%	-
Shares Outstanding (Basic)	12	11	11
Shares Outstanding (Diluted)	12	11	11
Shares Change (YoY)	-	6.20%	-
EPS (Basic)	632.31	630.08	308.13
EPS (Diluted)	632.31	630.08	308.13
EPS Growth	-	104.48%	-
Free Cash Flow	5,891	461.05	4,038
Free Cash Flow Per Share	476.65	40.41	375.87
Gross Margin	52.50%	50.01%	48.21%
Operating Margin	29.39%	31.14%	30.15%
Profit Margin	22.98%	24.26%	19.32%
Free Cash Flow Margin	17.32%	1.56%	23.57%
EBITDA	10,748	9,927	5,752
EBITDA Margin	31.61%	33.50%	33.58%
D&A For EBITDA	753.78	700.16	587.04
EBIT	9,994	9,227	5,165
EBIT Margin	29.39%	31.14%	30.15%
Effective Tax Rate	19.14%	19.95%	21.70%
Advertising Expenses	-	469.22	188.63

Source: S&P Global Market Intelligence. Standard template. Financial Sources.